fluorodeoxyglucose f18 has been researched along with Encephalopathy, Toxic in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burns, J; Freeman, C; Kim, SW; Kure Liu, C; Manza, P; Ramirez, V; Shokri-Kojori, E; Tomasi, DG; Volkow, ND; Wang, GJ; Wiers, CE; Zehra, A | 1 |
| Fujikawa, A; Fujiwara, M; Kuroda, K; Mitsuoka, K; Miyoshi, S; Naraoka, H; Noda, A; Shirakawa, T; Shiraki, K | 1 |
| Bortz, H; Corallo, CE; Coutsouvelis, J; Patil, S; Spencer, A | 1 |
| Ananth, M; Cadet, JL; Chachati, G; Delis, F; Gold, MS; Grant, SC; Kim, R; Masad, I; Muniz, JA; Rocco, MJ; Thanos, PK; Volkow, ND | 1 |
| Stübgen, JP | 1 |
| Beal, MF; Brownell, AL; Chen, YI; Cicchetti, F; Dedeoglu, A; Jenkins, BG; Wang, X; Yu, M | 1 |
6 other study(ies) available for fluorodeoxyglucose f18 and Encephalopathy, Toxic
| Article | Year |
|---|---|
Association Between Reduced Brain Glucose Metabolism and Cortical Thickness in Alcoholics: Evidence of Neurotoxicity.
Topics: Alcoholism; Atrophy; Case-Control Studies; Cerebral Cortex; Ethanol; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neuroimaging; Neuropsychological Tests; Neurotoxicity Syndromes; Positron-Emission Tomography | 2019 |
[18F]FDG-PET as an imaging biomarker to NMDA receptor antagonist-induced neurotoxicity.
Topics: Animals; Biomarkers; Cell Death; Dizocilpine Maleate; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Female; Fluorodeoxyglucose F18; Glucose; Gyrus Cinguli; Macaca fascicularis; Neurons; Neurotoxicity Syndromes; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 2013 |
Modifying chemotherapeutic management of a patient with Burkitt's lymphoma and pre-existing motor neurone disease.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Female; Fluorodeoxyglucose F18; Humans; Motor Neuron Disease; Neurotoxicity Syndromes; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction | 2015 |
Chronic Methamphetamine Effects on Brain Structure and Function in Rats.
Topics: Animals; Brain; Chronic Disease; Fluorodeoxyglucose F18; Male; Methamphetamine; Neurotoxicity Syndromes; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley; Substance-Related Disorders | 2016 |
Posterior reversible encephalopathy syndrome (PRES) after granulocyte-colony stimulating factor (G-CSF) therapy: a report of 2 cases.
Topics: Adult; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; In Vitro Techniques; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Neurotoxicity Syndromes; Positron-Emission Tomography; Young Adult | 2012 |
3-Nitropropionic acid-induced neurotoxicity--assessed by ultra high resolution positron emission tomography with comparison to magnetic resonance spectroscopy.
Topics: Acute Disease; Animals; Behavior, Animal; Body Weight; Brain; Choline; Chronic Disease; Disease Models, Animal; Disease Progression; Energy Metabolism; Fluorodeoxyglucose F18; Glucose; Lactic Acid; Magnetic Resonance Spectroscopy; Male; Motor Activity; Neostriatum; Neurotoxicity Syndromes; Nitro Compounds; Propionates; Rats; Rats, Sprague-Dawley; Succinic Acid; Tomography, Emission-Computed | 2004 |